Ads
related to: new blood thinner medication- Things You Should Know
View Important Safety Information.
Heart Failure Facts & Information.
- Patient Coverage
Pay As Little As $10.
Search For Patient Coverage.
- Coverage
Lowest Branded Copay Access.
Search For Coverage In Your Area.
- Clinical Trail Safety
Proven Safety Profile In Patients.
Review Clinical Research & Data.
- Hospital Results
Outcomes In The Hospital Setting.
Learn About Management Guideline.
- Safety Data
Safety & Warning Info For HCPs.
Review Clinical Trail Data On HF.
- Things You Should Know
Search results
Results From The WOW.Com Content Network
Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa.
Anticoagulants, or blood thinners, are one medication type for which researchers are interested in creating effective and fast-acting antidotes. This could allow for reversing their effects when ...
Other drugs on the list include AstraZeneca’s diabetes and heart failure treatment Farxiga and three drugs from Johnson & Johnson: the blood thinner Xarelto, the blood cancer treatment Imbruvica ...
An anticoagulant, commonly known as a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. [1] Some occur naturally in blood-eating animals, such as leeches and mosquitoes, which help keep the bite area unclotted long enough for the animal to obtain blood.
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [8] It is taken by mouth. [8]
The company earlier that month said it started a trial called OCEANIC-AFINA to test the experimental blood thinner in patients with a trial fibrillation who are ineligible for oral anticoagulant ...